← Back to Search

Other

Acetaminophen for Radical Prostatectomy

Phase 2 & 3
Waitlist Available
Led By Ashok K Hemal, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All men ages 40-75 undergoing bilateral robot assisted radical prostatectomy (RARP) with bilateral lymph node dissection with low-intermediate to high-risk localized prostate cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7
Awards & highlights

Study Summary

This study is evaluating whether a non-opioid pain medication can be used to reduce pain after prostatectomies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pharmaceutical Preparations
Fetal Distress
Pain

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental CohortExperimental Treatment5 Interventions
Multimodal Approach: Gabapentin (100mg TID) Ketorolac (15mg q6) Acetaminophen (1mg IV q6) Ketamine (1.5mg/kg) Ketorolac tromethamine (15mg or 30mg Q4)
Group II: Opioid Control CohortActive Control3 Interventions
One treatment selected: Tramadol (50mg) Hydrocodone-Acetaminophen (2.5mg/325mg) Oxycodone-Acetaminophen (2.5mg/325mg)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ketamine
2011
Completed Phase 4
~1090
Acetaminophen
2017
Completed Phase 4
~2030
Ketorolac tromethamine
2006
Completed Phase 3
~950
Ketorolac
2014
Completed Phase 4
~1760
Gabapentin
2013
Completed Phase 4
~1550

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,241 Previous Clinical Trials
1,004,237 Total Patients Enrolled
Ashok K Hemal, MDPrincipal InvestigatorWake Forest Health Sciences
1 Previous Clinical Trials
Ram Pathak, MDPrincipal InvestigatorWake Forest Health Sciences
1 Previous Clinical Trials
62 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025